ImmuCell Corporation Deferred Compensation Liability, Current
ImmuCell Corporation (ICCC) had Deferred Compensation Liability, Current of $19.59 thousand as of 2015-12-31, per its 10-K filed 2016-03-25.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredCompensationLiabilityCurrent · last filed 2016-03-25
- 2015-12-31: Deferred Compensation Liability, Current $19.59K.
- 2014-12-31: Deferred Compensation Liability, Current $0.00.
| Period end | Deferred Compensation Liability, Current |
|---|---|
| 2015-12-31 | $19.59K 10-K · filed 2016-03-25 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |